Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-31

Clinical Trial Update: Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating single-dose rifaximin versus azithromycin with loperamide adjunct for acute watery diarrhea, including traveler's diarrhea, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • Loperamide (loperamide)
  • Rifaximin (rifaximin)

Snippet

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine | Conditions: Diarrhoea;Acute, Diarrhea Travelers | Phase 4 | Status: RECRUITING